Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
This intro covers yearly drawdown trends for total market index funds, helping readers assess risk and anticipate potential downturns.
28,238 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
A suspected new THORChain breach spooks markets, sending RUNE lower as investors reassess cross-chain security and li...
A new Harvard Law study analyzes whether a safety-focused mission can survive investor pressure as Anthropic prepares...
In the wake of a $36 million breach, Humanity Protocol shifts from consumer crypto services to enterprise AI, led by ...
Joby Aviation has moved lower after hitting a peak. This guide weighs the risks and potential catalysts, and offers a...
SBI Holdings and Rakuten are teaming up to build an in-house crypto investment trust as Japan updates its crypto rule...
XRP sunk to a four-month low just under $1.15 as whale activity and ETF dynamics shift the supply-demand balance. Ana...
Legendary investor Michael Burry has taken a direct short against Micron Technology, challenging the view that AI-dri...
Institutional buyers stepped back into Bitcoin, lifting spot ETF inflows and signaling a shift back toward the market...
A dramatic legal verdict against a tech titan could reshape how investors view AI, crypto, and venture risk. This art...
Treasury's crypto policy lead is pushing for CLARITY Act passage by summer 2026 and signaling a cautious, deliberatel...
Eli Lilly's blockbuster first quarter puts the spotlight on a possible stock split as its high-priced shares approach...